Global Nucleic Acid Amplification Testing (NAAT) Market to Reach USD 9.36 Bn by 2032, Driven by Rising Prevalence of Infectious Diseases

The global Nucleic Acid Amplification Testing (NAAT) market is experiencing significant growth and is projected to reach a value of USD 9.36 billion by 2032. This market expansion is driven by several factors. Firstly, there is an increasing prevalence of infectious disorders, such as Sexually Transmitted Diseases (STDs), lung infections, and gastrointestinal infections. For example, malaria cases were estimated to be 219 million globally in 2019, with a majority occurring in Africa. As a result, the demand for NAAT testing, which aids in the accurate diagnosis of these conditions, is rising.

Furthermore, advancements in molecular diagnostics technology have contributed to the growing utilization of NAAT testing. Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) technology have greatly enhanced the speed and accuracy of NAAT testing. Additionally, the integration of automation and Artificial Intelligence (AI) in diagnostic testing has further improved the effectiveness and precision of NAAT tests. These technological developments have expanded the application of NAAT testing beyond traditional settings, such as hospitals and clinics, to include laboratories and even portable testing kits.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/2187

Some of the major companies operating in the global Nucleic Acid Amplification Testing (NAAT) market are:

• Abbott Laboratories
• Becton, Dickinson and Company
• bioMérieux SA
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• Qiagen N.V.
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Meridian Bioscience, Inc.
• Diasorin S.p.A.

The increasing demand for reliable and accurate diagnostic tests, especially in resource-limited environments, is expected to drive the revenue growth of the NAAT market during the forecast period. The market is anticipated to grow at a compound annual growth rate (CAGR) of 11%, reflecting the rising adoption and recognition of NAAT testing as a valuable diagnostic tool.

To know more about the report @ https://www.reportsanddata.com/report-detail/nucleic-acid-amplification-testing-naat-market

In summary, the global NAAT market is poised for substantial growth in the coming years due to the rising prevalence of infectious disorders, technological advancements in molecular diagnostics, and the increasing demand for accurate diagnostic tests in various healthcare settings.

By Technology Type Outlook     

·        PCR

·        LAMP

·        NASBA

·        TMA

·        Others

By End-Use Outlook      

·        Hospitals & Clinics

·        Diagnostic Laboratories

·        Research Institutes

·        Others

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2187

Strategic Development:

·        In 2021, Thermo Fisher Scientific, Inc. announced the release date of its TaqMan SARS-CoV-2 Mutation Panel. This diagnostic test is designed to detect variants of the SARS-CoV-2 virus. It aims to assist monitoring and surveillance operations in quickly and accurately identifying the most prevalent mutations of SARS-CoV-2.

·        Another collaboration took place in 2021 between Becton, Dickinson and Company (BD) and Scanwell Health. They partnered to develop and market a rapid at-home COVID-19 test. This test can be completed at home within 15 minutes and relies on a smartphone app that utilizes computer vision technology to interpret and analyze the test results.

·        In 2020, Meridian Bioscience, Inc. introduced the Revogene SARS-CoV-2 test. This diagnostic tool is highly accurate and reliable, capable of identifying SARS-CoV-2 in less than an hour. It aids in the swift identification of COVID-19 patients and is specifically designed for use in high-volume facilities.

·        Abbott Laboratories also made an announcement in 2020 about the release of their Alinity m Resp-4-Plex assay. This diagnostic test is known for its exceptional sensitivity and specificity, enabling the identification of respiratory pathogens, including SARS-CoV-2, in just five minutes. It is intended for use in clinics and hospitals to rapidly detect patients with respiratory infections and enhance patient care.

·        In the same year, Hologic, Inc. declared the launch of their Aptima SARS-CoV-2 assay. This highly accurate diagnostic test is capable of identifying SARS-CoV-2 in under three hours. It aids in the prompt identification of COVID-19 patients and is designed for use in high-volume facilities.

·        These advancements in diagnostic testing by various companies have contributed to the ongoing efforts in combating the COVID-19 pandemic by providing rapid and accurate tools for detecting the SARS-CoV-2 virus.

Key Advantages of Nucleic Acid Amplification Testing (NAAT) Report:

• Identification and analysis of the market size and competition
• Qualitative and quantitative analysis of the market data
• Data validated by industry experts after extensive primary and secondary research
• Extensive regional analysis of the Nucleic Acid Amplification Testing (NAAT) industry
• Profiling of key players along with their business overview, business strategies, deals and partnerships, and product portfolio
• SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
• Feasibility analysis and investment analysis to enable strategic investment decisions
• Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Conclusively, all aspects of the Nucleic Acid Amplification Testing (NAAT) market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

Latest Research Reports Published by Reports and Data:

Acute Radiation Syndrome Market- @ https://www.reportsanddata.com/report-detail/acute-radiation-syndrome-market

Automated Suturing Device Market- @ https://www.reportsanddata.com/report-detail/automated-suturing-device-market

Chronic Hepatitis B Virus Market- @ https://www.reportsanddata.com/report-detail/chronic-hepatitis-b-virus-market

Respiratory Distress Syndrome Market- @ https://www.reportsanddata.com/report-detail/respiratory-distress-syndrome-market

Hyperuricemia Treatment Market- @ https://www.reportsanddata.com/report-detail/hyperuricemia-treatment-market

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Read our Press Release @ https://www.reportsanddata.com/press-release/global-nucleic-acid-amplification-testing-naat-market

Trending Titles Compression Therapy Market | Orthopedic Biomaterials Market